Zentalis Pharmaceuticals, Inc. Income Tax Expense
Zentalis Pharmaceuticals, Inc. (ZNTL) reported Income Tax Expense of $138.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06
- Zentalis Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $138.00K.
- Zentalis Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $120.00K.
- Zentalis Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $442.00K.
- Zentalis Pharmaceuticals, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- Zentalis Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2025 was $442.00K, a 149.72% increase from fiscal 2024.
- Zentalis Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2024 was $177.00K.
- Zentalis Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2023 was -$601.00K.
- Zentalis Pharmaceuticals, Inc. income tax expense (benefit) for fiscal 2022 was -$469.00K.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $138.00K 10-Q · filed 2026-08-06 | $258.00K 10-Q · filed 2026-08-06 | $700.00K derived: sum of 3 quarters · filed 2026-08-06 | $700.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $120.00K 10-Q · filed 2026-05-12 | $562.00K derived: sum of 2 quarters · filed 2026-05-12 | $562.00K derived: sum of 3 quarters · filed 2026-05-12 | $562.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $442.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $442.00K derived: sum of 2 quarters · filed 2026-03-26 | $442.00K derived: sum of 3 quarters · filed 2026-08-06 | $442.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-10 | -$205.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$205.00K derived: sum of 3 quarters · filed 2026-08-06 | -$232.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | -$205.00K derived: sum of 2 quarters · filed 2026-05-12 | -$232.00K derived: sum of 3 quarters · filed 2026-05-12 | $34.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$232.00K derived: sum of 2 quarters · filed 2026-03-26 | $34.00K derived: sum of 3 quarters · filed 2026-03-26 | $177.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | -$27.00K 10-Q · filed 2025-11-10 | $239.00K derived: sum of 2 quarters · filed 2025-11-10 | $382.00K 10-Q · filed 2025-11-10 | $247.00K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-06-30 | $266.00K 10-Q · filed 2025-08-06 | $409.00K 10-Q · filed 2025-08-06 | $274.00K derived: sum of 3 quarters · filed 2026-03-26 | $305.00K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-03-31 | $143.00K 10-Q · filed 2025-05-14 | $8.00K derived: sum of 2 quarters · filed 2026-03-26 | $39.00K derived: sum of 3 quarters · filed 2026-03-26 | -$566.00K derived: sum of 4 quarters · filed 2026-03-26 |
| 2023-12-31 | -$135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$104.00K derived: sum of 2 quarters · filed 2026-03-26 | -$709.00K derived: sum of 3 quarters · filed 2026-03-26 | -$601.00K 10-K · filed 2026-03-26 |
| 2023-09-30 | $31.00K 10-Q · filed 2024-11-12 | -$574.00K derived: sum of 2 quarters · filed 2024-11-12 | -$466.00K 10-Q · filed 2024-11-12 | -$826.00K derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-06-30 | -$605.00K 10-Q · filed 2024-08-09 | -$497.00K 10-Q · filed 2024-08-09 | -$857.00K derived: sum of 3 quarters · filed 2025-03-26 | -$1.02M derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-03-31 | $108.00K 10-Q · filed 2024-05-07 | -$252.00K derived: sum of 2 quarters · filed 2025-03-26 | -$411.00K derived: sum of 3 quarters · filed 2025-03-26 | -$394.00K derived: sum of 4 quarters · filed 2025-03-26 |
| 2022-12-31 | -$360.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$519.00K derived: sum of 2 quarters · filed 2025-03-26 | -$502.00K derived: sum of 3 quarters · filed 2025-03-26 | -$469.00K 10-K · filed 2025-03-26 |
| 2022-09-30 | -$159.00K 10-Q · filed 2023-11-06 | -$142.00K derived: sum of 2 quarters · filed 2023-11-06 | -$109.00K 10-Q · filed 2023-11-06 | $50.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $17.00K 10-Q · filed 2023-08-09 | $50.00K 10-Q · filed 2023-08-09 | $209.00K derived: sum of 3 quarters · filed 2023-08-09 | -$488.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $33.00K 10-Q · filed 2023-05-10 | $192.00K derived: sum of 2 quarters · filed 2023-05-10 | -$505.00K derived: sum of 3 quarters · filed 2023-05-10 | -$460.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $159.00K 10-K · filed 2022-02-24 | -$538.00K derived: sum of 2 quarters · filed 2022-11-09 | -$493.00K derived: sum of 3 quarters · filed 2022-11-09 | -$297.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | -$697.00K 10-Q · filed 2022-11-09 | -$652.00K derived: sum of 2 quarters · filed 2022-11-09 | -$456.00K 10-Q · filed 2022-11-09 | -$30.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $45.00K 10-Q · filed 2022-08-09 | $241.00K 10-Q · filed 2022-08-09 | $667.00K derived: sum of 3 quarters · filed 2022-08-09 | $685.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $196.00K 10-Q · filed 2022-05-05 | $622.00K derived: sum of 2 quarters · filed 2022-05-05 | $640.00K derived: sum of 3 quarters · filed 2022-05-05 | $640.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $426.00K 10-K · filed 2022-02-24 | $444.00K derived: sum of 2 quarters · filed 2022-02-24 | $444.00K derived: sum of 3 quarters · filed 2022-02-24 | $444.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $18.00K 10-K · filed 2022-02-24 | $18.00K derived: sum of 2 quarters · filed 2022-02-24 | $18.00K 10-Q · filed 2021-11-10 | $18.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $0.00 10-K · filed 2022-02-24 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $1.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $0.00 10-K · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $1.00K derived: sum of 3 quarters · filed 2022-02-24 | $12.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 | $1.00K derived: sum of 2 quarters · filed 2021-03-25 | $12.00K derived: sum of 3 quarters · filed 2021-03-25 | $15.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $1.00K 10-K · filed 2021-03-25 | $12.00K derived: sum of 2 quarters · filed 2021-03-25 | $15.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $11.00K 10-K · filed 2021-03-25 | $14.00K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $3.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |